Breast cancer specialists discuss risk stratification and novel treatment strategies in high-risk HR+ HER2– early breast cancer

touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading breast cancer specialists discuss their perspectives on risk stratification and future therapies in HR+ HER2- early breast cancer. The experts Dr Carlos Barrios - Hospital São Lucas PUCRS, Porto Alegre, Brazil Prof. Dr. med. Nadia Harbeck - University of Munich (LMU), Munich, Germany Prof. Chiun-Sheng Huang - National Taiwan University Hospital, Taipei City, Taiwan This touchPODCAST is for HCPs only.  This activity is funded by an unrestricted independent medical education grant from Lilly USA, LLC (Lilly). This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchoncologyime.org/high-risk-hrpositive-her2negative-early-breast-cancer-risk-stratification-and-treatment-strategies/